Compare CVS Health Corp (CVS) vs iShares International Treasury Bond ETF (IGOV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs iShares International Treasury Bond ETF — how do they compare? CVS Health Corp trades at $86.3 (market cap $112.49B), while iShares International Treasury Bond ETF trades at $39.75 (market cap $1.31B). The key difference: CVS Health Corp is far larger — about 85.9× iShares International Treasury Bond ETF's market cap, and CVS Health Corp pays a 3.02% dividend while iShares International Treasury Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and iShares International Treasury Bond ETF for 92 Days on average.
| CVS | IGOV | |
|---|---|---|
Market Cap | $112.49B | $1.31B |
Volume | 8,467,392 | 493,216 |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $42.99 |
52-Week Low | $70.08 | $39.65 |
Typical Hold Time | 83 Days | 92 Days |
Enterprise Value | $174.83B | — |
Dividend Yield | 3.02% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.80, up 1.59% today, with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 27% upside. Recent quarterly earnings have consistently beaten expectations, with Q2 2026 EPS of $2.58 surpassing the $1.87 estimate. Revenue growth remains solid, reaching $402.07B in 2025, though net margins compressed to 1.18%. The technical picture shows bullish momentum with current price near key support at $87.
CVS presents a compelling value opportunity with attractive valuation multiples (P/E 23.21, P/S 0.27) and dividend stability, but faces margin pressure from healthcare cost trends. The stock's upside depends on maintaining earnings momentum amid reimbursement challenges and regulatory scrutiny highlighted in recent legal investigations.
IGOV is trading at $39.70, down 0.48% on the day, with technical indicators showing a bearish trend as moving averages signal selling pressure. The stock lacks available fundamental data for key valuation and profitability metrics, creating uncertainty around its financial health. Recent market news highlights rising global bond yields, which could impact interest-rate sensitive sectors.
The outlook remains cautious due to the bearish technical setup and absence of fundamental clarity. Investment opportunities depend on forthcoming financial disclosures, while risks include market volatility from rising yields and the stock's technical weakness. Investors require updated earnings reports to assess true valuation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About iShares International Treasury Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index and will invest at least 90% of its assets in fixed income securities included in the underlying index. The underlying index measures the performance of fixed-rate, local currency, investment-grade, sovereign bonds from certain developed markets. The fund is non-diversified.
Read more on IGOV →
